Alzheimer-type dementia prediction by sparse logistic regression using claim data.

Alzheimer-type dementia Health insurance claim data Long-term care insurance claim data Machine learning Prediction Sparse logistic regression

Journal

Computer methods and programs in biomedicine
ISSN: 1872-7565
Titre abrégé: Comput Methods Programs Biomed
Pays: Ireland
ID NLM: 8506513

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 06 11 2019
accepted: 30 05 2020
pubmed: 24 7 2020
medline: 15 5 2021
entrez: 24 7 2020
Statut: ppublish

Résumé

This study aimed to predict the risk of Alzheimer-type dementia for persons aged over 75 years old without receiving long-term care services using regularly collected claim data. A refined dataset including 48,123 persons was prepared from claim data of health insurance and long-term care insurance in a large city in the metropolitan area in Japan. The utilized features include the age and sex of subjects, 502 diseases based on ICD-10 diagnosis codes, and 107 prescription drugs based on therapeutic classes. The most important challenge in this work was feature selection form a large number of features. We adopted sparse logistic regression models with L0 regularization (SLR-L0) and L1 regularization (SLR-L1) as classification models based on machine learning. These regularizations enable feature selection by estimating sparse solution of non-zero coefficients in the model optimization. Predictions were performed by integrating 100 predictors trained by bootstrap samples. As a result, the area under the ROC curves (AUCs) were 0.663 for SLR-L0 and 0.660 for SLR-L1. These performances were similar, however, the average numbers of selected features were 13 out of a total of 611 for SLR-L0 and 253 for SLR-R1. The results indicate that SLR-L1 tended to include less useful features, whereas SLR-L0 narrowed down influential features. SLR-L0 might be more useful than SLR-L1 for practical use or the discussion of risk factors with medical experts.

Identifiants

pubmed: 32702573
pii: S0169-2607(20)31415-2
doi: 10.1016/j.cmpb.2020.105582
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105582

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest H. Fukunishi was a researcher at the Data Science Research Laboratories, NEC Corporation, Japan, from the beginning of this study to August 2017. Y. Kobayashi received the research fund based on a collaborative research project conducted by The University of Tokyo and NEC Corporation to investigate a method of preventing diseases. The authors declare no conflict of interest.

Auteurs

Hiroaki Fukunishi (H)

School of Computer Science, Tokyo University of Technology, 1404-1 Katakuramachi, Hachioji City, Japan. Electronic address: fukunishiha@stf.teu.ac.jp.

Mitsuki Nishiyama (M)

1st Government and Public Solutions Division, NEC Solution Innovators, Ltd., Japan.

Yuan Luo (Y)

Data Science Research Laboratories, NEC Corporation, 1753 Shimonumabe, Nakahara-ku, Kawasaki City, Japan.

Masahiro Kubo (M)

Data Science Research Laboratories, NEC Corporation, 1753 Shimonumabe, Nakahara-ku, Kawasaki City, Japan.

Yasuki Kobayashi (Y)

Department of Public Health, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH